JFL Life Sciences Ltd

JFL Life Sciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on JFL Life Sciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

JFL Life Sciences Ltd Share Price Chart

JFL Life Sciences Ltd Fundamentals

Traded Volume: 18,000

Market Cap(Cr): 41

Avg Traded Price 12.33

1 Year return -59.22%

Upper Circuit 12.5

Lower Circuit 12.2

P/E TTM 10.00

P/B Ratio 1.00

Traded Value(Cr) 2.25

EPS TTM 1.260

Book value 1.260

Dividend 0.00%

JFL Life Sciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights JFL Life Sciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the JFL Life Sciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -6.72%

1M +1.63%

3M -3.85%

1Y -59.22%

YTD null%

JFL Life Sciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights JFL Life Sciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 6000.00

Day Before Yesterday 18000.00

1W Avg 12000.00

1M Avg 27692.31

3M Avg 26448.98

JFL Life Sciences Ltd Technical Details

JFL Life Sciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 12

Support 2 12

Support 3 12

Pivot Point : 12

Resistance 1 13

Resistance 2 13

Resistance 3 13

JFL Life Sciences Ltd Corporate Actions

JFL Life Sciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on JFL Life Sciences Ltd’s capital allocation strategies.

All

Ex-Date 24-Sep-2024 Type B Description share@2:1 Record Date 24-Sep-2024 Ratio 2:1

Ex-Date 13-Sep-2024 Type D Description 0.25/share@2.50% Record Date 16-Sep-2024 Ratio 2.50

Dividends

Announcement Date 13-Sep-2024 Ex Dividend Date 13-Sep-2024 Dividend(%) 3

Bonus

Record Date 24-Sep-2024 Ex-Bonus Date 24-Sep-2024 Ratio 2:1

Splits

No Split has been declared by JFLLIFE

Others

Rights No Rights has been declared by JFLLIFE

JFL Life Sciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares JFL Life Sciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate JFL Life Sciences Ltd's relative performance and valuation against major competitors.

Stock Name Lasa Supergenerics Ltd ₹9.89 (+0.61%) M. Cap (Cr) 0.50 1 Yr Return (%) -59.63% P/E (TTM) -1.37 PB Ratio 0.59

Stock Name Checkpoint Trends Ltd ₹89.93 (+2.00%) M. Cap (Cr) 0.49 1 Yr Return (%) +578.21% P/E (TTM) 33.78 PB Ratio 88.11

Stock Name Medi Caps Ltd ₹36.30 (-1.63%) M. Cap (Cr) 0.45 1 Yr Return (%) -27.02% P/E (TTM) -7.98 PB Ratio 0.36

Stock Name JFL Life Sciences Ltd ₹12.50 (-3.10%) M. Cap (Cr) 0.41 1 Yr Return (%) -59.22% P/E (TTM) 9.92 PB Ratio 1.16

Stock Name Dipna Pharmachem Ltd ₹16.89 (+8.90%) M. Cap (Cr) 0.41 1 Yr Return (%) +150.22% P/E (TTM) 41.69 PB Ratio 1.06

Stock Name Gujarat Inject (Kerala) Ltd ₹27.25 (+4.37%) M. Cap (Cr) 0.40 1 Yr Return (%) +43.50% P/E (TTM) 92.85 PB Ratio 3.94

Stock Name Roopa Industries Ltd ₹50.19 (-0.02%) M. Cap (Cr) 0.39 1 Yr Return (%) -36.52% P/E (TTM) 20.16 PB Ratio 2.22

JFL Life Sciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by JFL Life Sciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 -3.53 Mar 2024 8.36 Mar 2023 -9.05 Mar 2022 2.32 Mar 2021 -5.87

PARTICULARS Investing Activities Mar 2025 -0.01 Mar 2024 -6.07 Mar 2023 0.86 Mar 2022 -0.71 Mar 2021 -1.64

PARTICULARS Financing Activities Mar 2025 3.54 Mar 2024 -2.31 Mar 2023 8.06 Mar 2022 -1.46 Mar 2021 7.25

PARTICULARS Net Cash Flow Mar 2025 0.00 Mar 2024 -0.03 Mar 2023 -0.13 Mar 2022 0.15 Mar 2021 -0.26

JFL Life Sciences Ltd Shareholding Pattern

This shows the ownership breakdown of JFL Life Sciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 67.47%

Public 32.54%

Other Institutions 0%

FII null%

Mutual Funds null%

About JFL Life Sciences Ltd

JFL Life Sciences Limited was incorporated as `JFL Life Sciences Private Limited' on April 25, 2010 as a Private Limited Company. Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to `JFL Life Sciences Limited', on March 3, 2022. The Company manufactures and market pharmaceutical products. Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS). Head quartered in Ahmedabad, Gujarat, Company is engaged in the business of manufacturing of pharmaceutical products. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain itscompetitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. In August 2022, the Company launched an IPO of 29,78,000 Equity Shares by raising funds aggregating to Rs. 18.16 Crore. The Company export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The Company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of the products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.For the purpose of identification equipment / machinery / containers are appropriately labelled to identify the stage of process. In case of tablets, the materials are quarantined after granulation, compression, coating and final packing operations for clearance from Q.A. before pursuing the next stage of process. In case of capsule, the materials are quarantined after mixing, filling and final packing operation for clearance from Q.A. before pursuing the next stage of process. Containers are labelled as `UNDER TEST' with details such as name, code number, quantity, no of containers, manufacturer's name, material code no, and material is then quarantined. A Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion.

Managing Director

Smiral Ashwinkumar Patel

Registered office 309 Satyam Mall Opp Saman Comp, Nr.Vishweshwar Mahadev Mandir, Ahmedabad, Gujarat, 380015

FAX :91-93772 95575

Background

Incorporation Year 2010

Face Value ₹10.00

Market Lot 2000

JFL Life Sciences Ltd Latest News

VIEW MORE NEWS

FAQs on JFL Life Sciences Ltd